{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:54:03Z","timestamp":1791492843411,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024QH561"],"award-info":[{"award-number":["ZR2024QH561"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jconrel.2025.114099","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:40:48Z","timestamp":1754415648000},"page":"114099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Biomimetic lipid nanocarriers overcome hypoxia barriers in lung cancer therapy"],"prefix":"10.1016","volume":"386","author":[{"given":"Chenghao","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Zhi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yan","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114099_bb0010","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.21037\/tlcr-22-137","article-title":"Comparison of the perioperative outcomes between robotic-assisted thoracic surgery and video-assisted thoracic surgery in non-small cell lung cancer patients with different body mass index ranges","volume":"11","author":"Qu","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0015","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1038\/s41467-024-51807-7","article-title":"Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: the multicenter SWORD phase 2 trial","volume":"15","author":"Ni","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0020","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/s41467-023-40813-w","article-title":"Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial","volume":"14","author":"Monjazeb","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114099_bb0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41591-023-02246-2","article-title":"Advancing neoadjuvant immunotherapy for lung cancer","volume":"29","author":"Conroy","year":"2023","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114099_bb0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","article-title":"Evolution of systemic therapy for stages I\u2013III non-metastatic non-small-cell lung cancer","volume":"18","author":"Chaft","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114099_bb0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41571-021-00539-4","article-title":"Therapeutic targeting of the hypoxic tumour microenvironment","volume":"18","author":"Singleton","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13046-021-02000-x","article-title":"Interfering with tumor hypoxia for radiotherapy optimization","volume":"40","author":"Telarovic","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114099_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-med-060619-022830","article-title":"Hypoxia reduction sensitizes refractory cancers to immunotherapy","volume":"73","author":"Jayaprakash","year":"2022","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114099_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0305-7372(03)00003-3","article-title":"Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies","volume":"29","author":"Shannon","year":"2003","journal-title":"Cancer Treat. Rev."},{"issue":"21","key":"10.1016\/j.jconrel.2025.114099_bb0060","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.1021\/acsnano.3c07763","article-title":"Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114099_bb0065","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1021\/acs.nanolett.8b02720","article-title":"Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer","volume":"18","author":"Song","year":"2018","journal-title":"Nano Lett."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114099_bb0070","doi-asserted-by":"crossref","first-page":"15381","DOI":"10.1021\/acsnano.1c07621","article-title":"Coli membrane vesicles as a catalase carrier for long-term tumor hypoxia relief to enhance radiotherapy","volume":"15","author":"Zai","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114099_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215178","article-title":"Engineering versatile nano-bacteria hybrids for efficient tumor therapy","volume":"488","author":"Wang","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.114099_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.150364","article-title":"MnO2 nanozyme with lanthanide-based radiosensitization for advanced radiotherapy by tumor microenvironment triggering STING pathway activation","volume":"486","author":"Tan","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0085","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"issue":"27","key":"10.1016\/j.jconrel.2025.114099_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904337","article-title":"Recent advances in nanostrategies capable of overcoming biological barriers for tumor management","volume":"32","author":"Huo","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114099_bb0095","article-title":"Hypoxia-adaptive penetration enhanced nanomedicine regulating cell\u2013internalization ability enabling the uniform distribution within tumors","volume":"505","author":"Liu","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"42","key":"10.1016\/j.jconrel.2025.114099_bb0100","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1002\/anie.201808615","article-title":"Revealing the immunogenic risk of polymers","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114099_bb0105","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.it.2021.09.006","article-title":"Host immunity and cellular responses to bacterial outer membrane vesicles","volume":"42","author":"Tiku","year":"2021","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114099_bb0110","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.7150\/thno.43402","article-title":"Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114099_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114099_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000489504","article-title":"Unique Francisella phosphatidylethanolamine acts as a potent anti-inflammatory lipid","volume":"10","author":"Ireland","year":"2018","journal-title":"J. Innate Immun."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114099_bb0125","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/s41589-020-00688-0","article-title":"Structural and functional consequences of reversible lipid asymmetry in living membranes","volume":"16","author":"Doktorova","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114099_bb0130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41589-020-0529-6","article-title":"Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape","volume":"16","author":"Lorent","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114099_bb0135","doi-asserted-by":"crossref","first-page":"2306808","DOI":"10.1002\/adma.202306808","article-title":"Lipid-centric design of plasma membrane-mimicking nanocarriers for targeted chemotherapeutic delivery","volume":"36","author":"Ning","year":"2024","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.jconrel.2025.114099_bb0140","doi-asserted-by":"crossref","first-page":"18570","DOI":"10.1021\/acsnano.5c02361","article-title":"Apoptotic cell-mimicking nanocarriers enhance splenic red pulp delivery through lipid pool modulation","volume":"19","author":"Ning","year":"2025","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114099_bb0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cmi.2010.30","article-title":"The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice","volume":"7","author":"Ma","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114099_bb0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114099_bb0155","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1021\/acsnano.9b01181","article-title":"Chain-length- and saturation-tuned mechanics of fluid nanovesicles direct tumor delivery","volume":"13","author":"Dai","year":"2019","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114099_bb0160","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.nanolett.9b03817","article-title":"Cancer-cell-membrane-coated nanoparticles with a Yolk\u2013Shell structure augment cancer chemotherapy","volume":"20","author":"Nie","year":"2020","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.colsurfb.2009.05.014","article-title":"Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization","volume":"73","author":"Shimanouchi","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003897","article-title":"Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer","volume":"10","author":"Reppel","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cas.13448","article-title":"ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer","volume":"109","author":"Esaki","year":"2018","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114099_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0185","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1038\/s41598-019-44318-9","article-title":"Role of lipid composition on the structural and mechanical features of axonal membranes: a molecular simulation study","volume":"9","author":"Saeedimasine","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114099_bb0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0927-7765(02)00071-1","article-title":"Preparation of ganglioside GM3 liposomes and their membrane properties","volume":"27","author":"Yokoyama","year":"2003","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"5961","key":"10.1016\/j.jconrel.2025.114099_bb0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114099_bb0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2014.12.018","article-title":"Improving drug delivery to solid tumors: priming the tumor microenvironment","volume":"201","author":"Khawar","year":"2015","journal-title":"J. Control. Release"},{"issue":"6976","key":"10.1016\/j.jconrel.2025.114099_bb0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/427695a","article-title":"Cancer cells compress intratumour vessels","volume":"427","author":"Padera","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0210","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114099_bb0215","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114099_bb0225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114099_bb0230","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41583-025-00908-3","article-title":"Lipid metabolism, remodelling and intercellular transfer in the CNS","volume":"26","author":"Vanherle","year":"2025","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114099_bb0235","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41569-021-00538-z","article-title":"High-density lipoproteins, reverse cholesterol transport and atherogenesis","volume":"18","author":"Pownall","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114099_bb0240","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41565-023-01455-7","article-title":"Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona","volume":"18","author":"Tang","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114099_bb0245","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCRESAHA.119.316424","article-title":"LDL receptor regulates the reverse transport of macrophage-derived unesterified cholesterol via concerted action of the HDL-LDL axis: insight from mouse models","volume":"127","author":"Ced\u00f3","year":"2020","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114099_bb0250","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1021\/jp804641e","article-title":"Interactions between DMPC liposomes and the serum blood proteins HSA and IgG","volume":"113","author":"Sab\u00edn","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2025.114099_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ifset.2022.103155","article-title":"Effect of phospholipids on membrane characteristics and storage stability of liposomes","volume":"81","author":"Song","year":"2022","journal-title":"Innov. Food Sci. Emerg. Technol."},{"key":"10.1016\/j.jconrel.2025.114099_bb0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.actbio.2021.07.074","article-title":"Spotlight on the protein corona of liposomes","volume":"134","author":"Onishchenko","year":"2021","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.colsurfa.2004.07.030","article-title":"Physical characterization of surface-modified liposomes by incorporation of gangliosides designed for immunotherapies","volume":"251","author":"Zanin","year":"2004","journal-title":"Colloids Surf. A Physicochem. Eng. Aspects"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114099_bb0270","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Laura Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114099_bb0275","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1021\/ar500190q","article-title":"Nanoparticle\u2013cell interactions: molecular structure of the protein corona and cellular outcomes","volume":"47","author":"Fleischer","year":"2014","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114099_bb0280","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1038\/s41467-020-18237-7","article-title":"Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association","volume":"11","author":"Mohammad-Beigi","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114099_bb0285","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/ar040133f","article-title":"Fluctuating enzymes: lessons from single-molecule studies","volume":"38","author":"Min","year":"2005","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114099_bb0290","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1021\/acscatal.7b00838","article-title":"An inverse Michaelis\u2013Menten approach for interfacial enzyme kinetics","volume":"7","author":"Kari","year":"2017","journal-title":"ACS Catal."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:42:32Z","timestamp":1777192952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925007102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"alternative-id":["S0168365925007102"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114099","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic lipid nanocarriers overcome hypoxia barriers in lung cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114099"}}